Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3916 results

Sort By:

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Study ID: NCT06900595
Start Date: 2025-07-31
End Date: 2029-06-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

Biospecimen Collection

Cabozantinib

Cemiplimab

Computed Tomography

Magnetic Resonance Imaging

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

TRACK-TBI Precision Medicine Part 3 - Option II

Study ID: NCT06790095
Start Date: 2025-08
End Date: 2026-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

26

Intervention / Treatment

Cyclosporine (CsA)

Placebo

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

24GUT540 : Meeting of Breast Cancer Patients and Pathologists

Study ID: NCT07040514
Start Date: 2025-08-01
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Questionnaires of Patient understanding of Pathologist input

Sponsor

Dartmouth-Hitchcock Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Pain and Smoking Study - Interactive Voice Response

Study ID: NCT06442514
Start Date: 2025-08-04
End Date: 2028-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

220

Intervention / Treatment

PASS-IVR

Treatment as Usual

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Study ID: NCT06868914
Start Date: 2025-07-22
End Date: 2028-01-13
Study Type

Interventional

Study Phase

Phase1

No. of Participants

35

Intervention / Treatment

TMS (Magventure Magpro 100 With Magoption)

Sponsor

National Institute on Drug Abuse (NIDA)

Source: clinicaltrials.gov

Share:
Add to list

Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations

Study ID: NCT07053514
Start Date: 2027-07
End Date: 2028-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

139

Intervention / Treatment

SD-ART

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

The Effectiveness of Hyaluronic Acid in Bone Regeneration

Study ID: NCT07031895
Start Date: 2025-08-02
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

a bovine-derived graft/xenograft enriched with hyaluronic acid

a standart bovine-derived graft/xenograft

Sponsor

TC Erciyes University

Source: clinicaltrials.gov

Share:
Add to list

Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus

Study ID: NCT06913023
Start Date: 2026-01-05
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

74

Intervention / Treatment

Semaglutide 3 MG [Rybelsus]

Semaglutide 7 MG [Rybelsus]

Semaglutide 14 MG [Rybelsus]

Placebo Oral Tablet

Sponsor

University Health Network, Toronto

Source: clinicaltrials.gov

Share:
Add to list

Comparing the Efficacy of Lyophilized Self Growth Factor Versus PRP Injection for Knee OA

Study ID: NCT06932614
Start Date: 2025-08-01
End Date: 2026-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Lyophilized self growth factor

Platelet-Rich Plasma(PRP)

Placebo

Sponsor

Tri-Service General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Brain Stimulation to the Hippocampus in Schizophrenia

Study ID: NCT07010614
Start Date: 2025-10-01
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Intracranial electrodes

TMS

TMS sham

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list